EUVIMEDEUVIMED entdecken
Multizentrische Studie

Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors

Yi-Wei Kao, Kun-Chi Yen, Shao-Wei Chen, Tze-Fan Chao, Yi-Hsin Chan iD

Diabetes, Obesity and Metabolism · 2024-09 · 26 (9) · 3868-3879

DOI: 10.1111/dom.15734 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024-07. Verfasst von Yi-Wei Kao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Statistics and Information Science, Ming Chuan University, Taoyuan City, Taiwan. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Glomerular Filtration Rate, Albuminuria, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Chang Gung Memorial Hospital, Linkou, Taiwan, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To assess if early change in albuminuria was linked to an initial change in estimated glomerular filtration rate (eGFR) and long‐term kidney outcomes in people with type 2 diabetes (T2D) receiving sodium‐glucose cotransporter‐2 (SGLT2) inhibitors.

Methods

Using a medical database from a multicentre healthcare institute in Taiwan, we retrospectively enrolled 8310 people receiving SGLT2 inhibitors from 1 June 2016 to 31 December 2021. We compared the risks of initial eGFR decline, major adverse renal events (MARE; >50% eGFR reduction or development of end‐stage kidney disease), major adverse cardiovascular events (MACE), or hospitalization for heart failure (HHF) using a Cox proportional hazards model.

Results

In all, 36.8% ( n = 3062) experienced a >30% decrease, 21.0% ( n = 1743) experienced a 0%–30% decrease, 14.4% ( n = 1199) experienced a 0%–30% increase, and 27.7% ( n = 2306) experienced a >30% increase in urine albumin‐to‐creatine ratio (UACR) after 3 months of SGLT2 inhibitor treatment. Greater acute eGFR decline at 3 months correlated with greater UACR reduction: −3.6 ± 10.9, −2.0 ± 9.5, −1.1 ± 8.6, and −0.3 ± 9.7 mL/min/1.73 m 2 for the respective UACR change groups ( p < 0.001). Over a median of 29.0 months, >30% UACR decline was associated with a higher risk of >30% initial eGFR decline (hazard ratio [HR] 2.68, 95% confidence interval [CI] 1.61–4.47]), a lower risk of MARE (HR 0.66, 95% CI 0.48–0.89), and a comparable risk of MACE or HHF after multivariate adjustment ( p < 0.05). The nonlinear analysis showed early UACR decline was linked to a lower risk of MARE but a higher risk of initial steep eGFR decline of >30%.

Conclusion

Physicians should be vigilant for the potential adverse effects of abrupt eGFR dipping associated with a profound reduction in UACR, despite the favourable long‐term kidney outcomes in the population with T2D receiving SGLT2 inhibitor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsGlomerular Filtration RateAlbuminuriaDiabetes Mellitus, Type 2Diabetic NephropathiesHumansFemaleMaleMiddle AgedRetrospective StudiesAgedTaiwanKidneyTreatment Outcome

Stichwörter der Autor:innen

estimated glomerular filtration ratesodium‐glucose cotransporter‐2 inhibitortype 2 diabetes mellitusurine albumin‐to‐creatinine ratio

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Applied Statistics and Information Science, Ming Chuan University, Taoyuan City, Taiwan.
  • Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.
  • The Cardiovascular Department, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Institute of Clinical Medicine, Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Yi-Hsin Chan

Förderung

  • Ministry of Science and Technology, Taiwan
  • Chang Gung Memorial Hospital, Linkou, Taiwan
  • National Science and Technology Council
  • Chang Gung Memorial Hospital

Zitieren

APA

Kao, Y. W., Yen, K. C., Chen, S. W., Chao, T. F., & Chan, Y. H. (2024). Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors. Diabetes, Obesity and Metabolism, 26(9), 3868-3879. https://doi.org/10.1111/dom.15734

Vancouver

Kao YW, Yen KC, Chen SW, Chao TF, Chan YH. Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors. Diabetes, Obesity and Metabolism. 2024;26(9):3868-3879. doi:10.1111/dom.15734

BibTeX
@article{Kao2024,
  author = {Kao, Yi-Wei and Yen, Kun-Chi and Chen, Shao-Wei and Chao, Tze-Fan and Chan, Yi-Hsin},
  title = {Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {9},
  pages = {3868--3879},
  doi = {10.1111/dom.15734}
}
Kostenlos starten →